Latest Selectin Stories
The removal of rare tumor cells circulating in the blood might be possible with the use of biomolecules bound to dendrimers, highly branched synthetic polymers, which could efficiently sift and capture the diseased cells.
CAMBRIDGE, Mass. Dec. 10 /PRNewswire/ -- The US Army, through the Telemedicine and Advanced Technology Research Center (TATRC), has awarded Energid Technologies a contract to develop a robotic approach to airway management.
GlycoMimetics has initiated a Phase I clinical trial for GMI-1070, its lead drug candidate for the treatment of vaso-occlusive crisis of sickle cell disease. The Phase I trial will evaluate the safety and pharmacokinetics of a single intravenous dose of GMI-1070 at a range of dose levels.
GlycoMimetics, Inc., a privately held company developing a new class of glycobiology-based therapies for a broad range of indications, today announced it has initiated a Phase 1 clinical trial for GMI-1070, its lead drug candidate for the treatment of vaso-occlusive crisis of sickle cell disease.
When Michael King captures cancer cells, he kills them. When he captures stem cells, he harvests them for later use in tissue engineering, bone marrow transplants, and other applications that treat human disease and improve health.
- A person in a secondary role, specifically the second most important character (after the protagonist).